| Title |
Mania following ketamine abuse
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, January 2016
|
| DOI | 10.2147/ndt.s97696 |
| Pubmed ID | |
| Authors |
Yuan-Yuan Lu, Chieh-Hsin Lin, Hsien-Yuan Lane |
| Abstract |
Ketamine, a noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, has multiple clinical uses. On the other hand, ketamine abuse or recreational use has been gaining increasing attention. Induction of mania and psychotic symptoms has been reported in a patient receiving IV ketamine therapy for reflex sympathetic dystrophy. We here report a 26 year-old man who abused ketamine by inhalation for 12 months and developed manic-like symptoms after ketamine use. This case suggests a possible relationship between manic symptoms and ketamine abuse. To the best of our knowledge, this may be the first report regarding mania after recreational use of ketamine. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 2% |
| Unknown | 46 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 8 | 17% |
| Student > Master | 8 | 17% |
| Student > Doctoral Student | 7 | 15% |
| Researcher | 6 | 13% |
| Student > Ph. D. Student | 3 | 6% |
| Other | 3 | 6% |
| Unknown | 12 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 6 | 13% |
| Medicine and Dentistry | 6 | 13% |
| Agricultural and Biological Sciences | 5 | 11% |
| Neuroscience | 5 | 11% |
| Biochemistry, Genetics and Molecular Biology | 3 | 6% |
| Other | 6 | 13% |
| Unknown | 16 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2023.
All research outputs
#15,091,226
of 25,373,627 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,408
of 3,132 outputs
Outputs of similar age
#201,168
of 399,674 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#45
of 70 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,674 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.